Ob/Gyn Medical News about Endometrial Neoplasms

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

4. 2008 Exclusive Survey—Earnings: Good news for primary care income

5. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Predictive power of sexual hormones and tumor markers in endometrial cancer
Archives of Gynecology and Obstetrics, 09/30/09

Kanat–Pektas M et al. – Because serum concentrations of CA–125 can be elevated in various malignancies, it is obvious that it is neither specific nor accurately diagnostic for endometrial tumors. What is more, the distinct effects of physiological factors on prolactin secretion shadow the credibility of this hormone in early diagnosis of endometrial tumors. Thus, either prolactin or CA–125 is far from being utilized as the sole entity for screening endometrial cancer.

<< Previous
Prospective assessment of overactive bladder symptoms in women...

Next >>
A hypothesis and model of reduced fetal movement as a common...

Endometrial Cancer
American Family Physician, 11/12/09 Relevance Score: 67%%

Use of Nonsteroidal Antiinflammatory Drugs and Risk of Endometrial Cancer
American Journal of Epidemiology, 11/09/09 Relevance Score: 66%%

Intraoperative evaluation of myometrial invasion and histological type and grade in endometrial cancer: diagnostic value of frozen section
Archives of Gynecology and Obstetrics, 10/30/09 Relevance Score: 66%%

Uterine arterial embolization: collagen analysis of endometrial/uterine biopsy pre and after procedure
Gynecological Surgery, 10/20/09 Relevance Score: 66%%

Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen
Cochrane Reviews, 10/09/09 Relevance Score: 66%%